Connor, Clark & Lunn Investment Management (CC&L)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $61K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $15K | Buy |
|
|||||
|
2019
Q4 | $17K | Sell |
|
|||||
|
2019
Q3 | $26K | Sell |
|
|||||
|
2019
Q2 | $58K | Sell |
|
|||||
|
2019
Q1 | $85K | Buy |
|
|||||
|
2018
Q4 | $35K | Sell |
|
|||||
|
2018
Q3 | $107K | Buy |
|
|||||
|
2018
Q2 | $43K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $983K | Sell |
|
|||||
|
2017
Q1 | $2.16M | Sell |
|
|||||
|
2016
Q4 | $968K | Buy |
|
|||||
|
2016
Q3 | $1.08M | Buy |
|
|||||
|
2016
Q2 | $866K | Buy |
|
|||||
|
2016
Q1 | $3.33M | Buy |
|
|||||
|
2015
Q4 | $4.6M | Buy |
|
|||||
|
2015
Q3 | $4.07M | Buy |
|
|||||
|
2015
Q2 | $705K | Buy |
|
|||||
|
2015
Q1 | $678K | Buy |
|
|||||
|
2014
Q4 | $696K | Buy |
|